These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30454946)

  • 1. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014.
    Tarantola A; Ly S; Chan M; In S; Peng Y; Hing C; Taing CN; Phoen C; Ly S; Cauchemez S; Buchy P; Dussart P; Bourhy H; Mary JY
    Vaccine; 2019 Oct; 37 Suppl 1():A118-A127. PubMed ID: 30454946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
    Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A
    Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Warrell MJ
    Vaccine; 2019 Feb; 37(9):1131-1136. PubMed ID: 30691982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
    Krzowska-Firych J; Tomasiewicz K; Kozøowska A
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use.
    Tarantola A; Ly S; In S; Ong S; Peng Y; Heng N; Buchy P
    J Travel Med; 2015; 22(5):348-52. PubMed ID: 26173470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
    WHO Rabies Modelling Consortium
    Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.
    Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M
    Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy".
    Bharti OK; Thakur B; Rao R
    Vaccine; 2019 Oct; 37 Suppl 1():A128-A131. PubMed ID: 31395454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in human rabies prophylaxis.
    Warrell MJ
    Rev Sci Tech; 2018 Aug; 37(2):629-647. PubMed ID: 30747121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience.
    Giesen A; Gniel D; Malerczyk C
    Expert Rev Vaccines; 2015 Mar; 14(3):351-67. PubMed ID: 25683583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A shorter post-exposure prophylaxis regimen for rabies, Pakistan.
    Salahuddin N; Ansari N; Gohar MA
    Bull World Health Organ; 2021 Jul; 99(7):506-513. PubMed ID: 34248223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
    Madhusudana SN; Anand NP; Shamsundar R
    Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
    Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of health seeking behaviour following rabies exposure in Ethiopia.
    Beyene TJ; Mourits MCM; Revie CW; Hogeveen H
    Zoonoses Public Health; 2018 Jun; 65(4):443-453. PubMed ID: 29524317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines.
    Tarantola A; Tejiokem MC; Briggs DJ
    Vaccine; 2019 Oct; 37 Suppl 1():A88-A93. PubMed ID: 30471958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessibility to rabies centers and human rabies post-exposure prophylaxis rates in Cambodia: A Bayesian spatio-temporal analysis to identify optimal locations for future centers.
    Baron JN; Chevalier V; Ly S; Duong V; Dussart P; Fontenille D; Peng YS; Martínez-López B
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010494. PubMed ID: 35771752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
    Changalucha J; Steenson R; Grieve E; Cleaveland S; Lembo T; Lushasi K; Mchau G; Mtema Z; Sambo M; Nanai A; Govella NJ; Dilip A; Sikana L; Ventura F; Hampson K
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A45-A53. PubMed ID: 30309746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.